iAnthus Capital Holdings Inc. C.IAN

Alternate Symbol(s): ITHUF

Healthcare Cannabis

iAnthus Capital Holdings, Inc. is a vertically integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities. The Company is also a developer, producer, and distributor of branded cannabis and cannabidiol (CBD) products in the United States. Through its subsidiaries, the Company owns and/or operates 37 dispensaries and eight cultivation and/or processing facilities in seven United States. Its multi-state operations encompass a full range of medical and adult-use cannabis enterprises, including cultivation, processing, product development, wholesale-distribution, and retail. The Company offers various cannabis products, which includes flower and trim, products containing cannabis flower and trim, such as packaged flower and pre-rolls; cannabis infused products, such as topical creams and edibles and products containing cannabis extracts, such as vape cartridges, concentrates, live resins, wax products, oils, and tinctures.

CSE:IAN - Post by User

iAnthus Capital Holdings Inc.

Bullboard Posts

Post by sammydlon May 17, 2018 3:08pm

220 Views

Post# 28047930

Massive share price gain coming.

Very undervalued play, shot up same time last year from 0.17 to 0.29, Q1 results in next week will be even bigger then last's year's results.

bmoe80 wrote:
Stock up, average down. Good buy in price right now. Meeting is next Thursday and Q1 results will be announced by then or on that day. From what I gather, it should be one of the best quarters, we should also be seeing some more positive numbers/contracts coming through. Last year this time stock ran up to 0.29 on the revenue growth results, hopefully we see it testing this January's highs of 0.21 and better.

Market hasn't taken into account it's growing revenue stream over the past year, or einsteinium/cryptocurrency pontential, or potential for "Voxtel in the political arena its planned launch in crypto contributions in the Fall of 2018.

Definitely very undervalued at current stock price, especially compared to similiar stocks like MOS which had 2017 revenues of less then $3 milliion compared to ATW's $12 million, but trades at a much higher market cap of $25 million. This stock should be trading well about the 0.30/0.40's.